Suchergebnisse - "Hou, Zhiguo"

PubPharm (26)

1

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC : a drug-drug interaction study

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Ma, Y. | Chen, Q. | Zhang, Y. | +11

2

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD) : a prospective, single-arm, multicenter, phase IV study

enthalten in: BMC medicine | 2023

von Li, J. | Qin, S. | Wen, L. | +32

3

On-Demand Removable Self-Healing and pH-Responsive Europium-Releasing Adhesive Dressing Enables Inflammatory Microenvironment Modulation and Angiogenesis for Diabetic Wound Healing

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2023

von Fu, M. | Zhao, Y. | Wang, Y. | +7

4

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

enthalten in: Nature communications | 2022

von Tang, Z. | Wang, Y. | Liu, D. | +18

5

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer : The APPROVE Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Wang, T. | Tang, J. | Yang, H. | +14

6

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02) : a single-arm, open-label, phase 2 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Meng, X. | Wu, T. | Hong, Y. | +21

CommentIn: Lancet Gastroenterol Hepatol. 2022 Mar;7(3):200-201. - PMID 34998470

7

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer : The REALITY Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Lin, Y. | Qin, S. | Li, Z. | +22

CommentIn: JAMA Oncol. 2022 Feb 1;8(2):250-251. - PMID 34913944

8

Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer

enthalten in: Journal for immunotherapy of cancer | 2021

von Lin, Z. | Cai, M. | Zhang, P. | +21

ErratumIn: J Immunother Cancer. 2022 Feb;10(2):. - PMID 35110361

9

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC : The Phase III ACTIVE Study (CTONG1706)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Zhao, H. | Yao, W. | Min, X. | +23

CommentIn: J Thorac Oncol. 2021 Sep;16(9):1426-1428. - PMID 34425993

10

Sulfur-Rich Phosphorus Sulfide Molecules for Use in Rechargeable Lithium Batteries

enthalten in: Angewandte Chemie (International ed. in English) | 2017

von Li, X. | Liang, J. | Lu, Y. | +4